{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T00:20:58Z","timestamp":1795047658403,"version":"4.10.2"},"reference-count":71,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chagas disease is a parasitic infection caused by Trypanosoma cruzi. Although the host immune response has been extensively studied, important knowledge gaps remain, particularly regarding the complex and multifaceted immune evasion mechanisms employed by the parasite, both at the innate and adaptive levels. In recent years, multiple promising vaccine candidates have been developed, but further evaluation is needed across the different phases of clinical trials. Therefore, the aim of this review is to examine the host immune response to T. cruzi, the parasite\u2019s immune evasion strategies and recent advances in vaccine development aimed at controlling infection.<\/jats:p>","DOI":"10.1093\/trstmh\/traf109","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T11:36:24Z","timestamp":1758022584000},"page":"95-106","source":"Crossref","is-referenced-by-count":3,"title":["Chagas disease: host responses, parasite evasion and vaccine advances"],"prefix":"10.1093","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8872-872X","authenticated-orcid":false,"given":"H\u00e9ctor","family":"Serrano-Coll","sequence":"first","affiliation":[{"name":"Tropical medicine, Instituto Colombiano de Medicina Tropical-Universidad CES , Cra. 43A #52 Sur - 99, Medell\u00edn 055450 ,","place":["Colombia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"issue":"2","key":"2026020210305562600_bib1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.idc.2012.03.002","article-title":"American trypanosomiasis (Chagas disease)","volume":"26","author":"Rassi","year":"2012","journal-title":"Infect Dis Clin North Am"},{"issue":"5","key":"2026020210305562600_bib2","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.3390\/ijms19051277","article-title":"Comparative analysis of repetitive DNA between the main vectors of chagas disease: Triatoma infestans and Rhodnius prolixus","volume":"19","author":"Pita","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2026020210305562600_bib3","first-page":"88","article-title":"Comparison of four typing methods for Aeromonas species","volume":"6","author":"Altwegg","year":"1988","journal-title":"J Diarrhoeal Dis Res"},{"issue":"1","key":"2026020210305562600_bib4","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4269\/ajtmh.23-0380","article-title":"An outbreak of acute chagas disease possibly spread through oral transmission involving animal reservoirs in Eastern Colombia","volume":"110","author":"Guti\u00e9rrez","year":"2024","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"2026020210305562600_bib5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/1471-0528.12396","article-title":"Frequency of the congenital transmission of Trypanosoma cruzi: a systematic review and meta-analysis","volume":"121","author":"Howard","year":"2014","journal-title":"BJOG"},{"issue":"29","key":"2026020210305562600_bib6","first-page":"798","article-title":"Chagas disease after organ transplantation\u2013Los Angeles, California, 2006","volume":"55","author":"Centers for Disease Control and Prevention (CDC)","year":"2006","journal-title":"Morb Mortal Wkly Rep"},{"issue":"10","key":"2026020210305562600_bib7","doi-asserted-by":"crossref","first-page":"e429","DOI":"10.1097\/JOM.0000000000001674","article-title":"Work-related Trypanosoma cruzi exposures","volume":"61","author":"Budnick","year":"2019","journal-title":"J Occup Environ Med"},{"key":"2026020210305562600_bib8","first-page":"100832","article-title":"Clinical features of Chagas disease progression and severity","volume":"37","author":"Nunes","year":"2024","journal-title":"Lancet Reg Health Am"},{"issue":"14","key":"2026020210305562600_bib9","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1017\/S0031182017001469","article-title":"Biological factors that impinge on Chagas disease drug development","volume":"144","author":"Francisco","year":"2017","journal-title":"Parasitology"},{"key":"2026020210305562600_bib10","first-page":"100881","article-title":"The epidemiology of Chagas disease in the Americas","volume":"37","author":"Cucunub\u00e1","year":"2024","journal-title":"Lancet Reg Health Am"},{"issue":"2","key":"2026020210305562600_bib11","doi-asserted-by":"crossref","first-page":"e0011898","DOI":"10.1371\/journal.pntd.0011898","article-title":"The importance of estimating the burden of disease from foodborne transmission of Trypanosoma cruzi","volume":"18","author":"Robertson","year":"2024","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"2026020210305562600_bib12","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5334\/gh.1280","article-title":"The burden of Chagas disease in the contemporary world: the RAISE study","volume":"19","author":"Ribeiro","year":"2024","journal-title":"Glob Heart"},{"issue":"1","key":"2026020210305562600_bib13","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/pathogens14010024","article-title":"Epidemiology of Chagas disease in the United States of America: a short review and some comments","volume":"14","author":"Klotz","year":"2025","journal-title":"Pathogens"},{"issue":"2","key":"2026020210305562600_bib14","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3390\/pathogens12020282","article-title":"A review on the immunological response against Trypanosoma cruzi","volume":"12","author":"Macaluso","year":"2023","journal-title":"Pathogens"},{"issue":"6","key":"2026020210305562600_bib15","doi-asserted-by":"crossref","first-page":"534","DOI":"10.3390\/life11060534","article-title":"Mechanisms associated with Trypanosoma cruzi host target cell adhesion, recognition and internalization","volume":"11","author":"Rodr\u00edguez-Bejarano","year":"2021","journal-title":"Life"},{"issue":"4","key":"2026020210305562600_bib16","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3390\/pathogens14040392","article-title":"Trypanosoma cruzi\/Triatomine interactions-a review","volume":"14","author":"Schaub","year":"2025","journal-title":"Pathogens"},{"issue":"Suppl 2","key":"2026020210305562600_bib17","first-page":"49","article-title":"Kissing bugs in the United States: risk for vector-borne disease in humans","volume":"8","author":"Klotz","year":"2014","journal-title":"Environ Health Insights"},{"issue":"4","key":"2026020210305562600_bib18","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3390\/life14040488","article-title":"The end justifies the means: chagas disease from a perspective of the host-Trypanosoma cruzi interaction","volume":"14","author":"Rossi","year":"2024","journal-title":"Life"},{"issue":"3","key":"2026020210305562600_bib19","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1128\/CMR.00063-10","article-title":"Pathogenesis of Chagas\u2019 disease: parasite persistence and autoimmunity","volume":"24","author":"Teixeira","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"2026020210305562600_bib20","doi-asserted-by":"crossref","first-page":"507874","DOI":"10.1155\/2012\/507874","article-title":"The immune response to Trypanosoma cruzi: role of toll-like receptors and perspectives for vaccine development","volume":"2012","author":"Rodrigues","year":"2012","journal-title":"J Parasitol Res"},{"issue":"3","key":"2026020210305562600_bib21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/09511920410001713565","article-title":"Trypanosoma cruzi and its components as exogenous mediators of inflammation recognized through toll-like receptors","volume":"13","author":"Campos","year":"2004","journal-title":"Mediat Inflamm"},{"issue":"13","key":"2026020210305562600_bib22","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1016\/j.molimm.2008.05.004","article-title":"TLR2, TLR4 and TLR9 are differentially modulated in liver lethally injured from BALB\/c and C57BL\/6 mice during Trypanosoma cruzi acute infection","volume":"45","author":"Carrera-Silva","year":"2008","journal-title":"Mol Immunol"},{"key":"2026020210305562600_bib23","volume-title":"Cellular and molecular immunology","author":"Abbas","year":"2015."},{"issue":"11","key":"2026020210305562600_bib24","doi-asserted-by":"crossref","first-page":"7917","DOI":"10.4049\/jimmunol.181.11.7917","article-title":"A novel IFN regulatory factor 3-dependent pathway activated by trypanosomes triggers IFN-beta in macrophages and fibroblasts","volume":"181","author":"Chessler","year":"2008","journal-title":"J Immunol"},{"issue":"2","key":"2026020210305562600_bib25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1365-2249.2003.02294.x","article-title":"Role of IFN-alpha\/beta and IL-12 in the activation of natural killer cells and interferon-gamma production during experimental infection with Trypanosoma cruzi","volume":"134","author":"Une","year":"2003","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"2026020210305562600_bib26","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.coi.2006.05.002","article-title":"Natural killer cells as an initial defense against pathogens","volume":"18","author":"Lodoen","year":"2006","journal-title":"Curr Opin Immunol"},{"issue":"3","key":"2026020210305562600_bib27","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.4049\/jimmunol.0902254","article-title":"Cutting edge: nucleotide-binding oligomerization domain 1-dependent responses account for murine resistance against Trypanosoma cruzi infection","volume":"184","author":"Silva","year":"2010","journal-title":"J Immunol"},{"key":"2026020210305562600_bib28","doi-asserted-by":"crossref","first-page":"108648","DOI":"10.1016\/j.clim.2020.108648","article-title":"Immune modulating effects of receptor interacting protein 2 (RIP2) in autoinflammation and immunity","volume":"223","author":"Hofmann","year":"2021","journal-title":"Clin Immunol"},{"issue":"10","key":"2026020210305562600_bib29","doi-asserted-by":"crossref","first-page":"e2469","DOI":"10.1371\/journal.pntd.0002469","article-title":"NLRP3 controls Trypanosoma cruzi infection through a caspase-1-dependent IL-1R-independent NO production","volume":"7","author":"Gon\u00e7alves","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"2026020210305562600_bib30","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3389\/fmicb.2017.00607","article-title":"The complement system: a prey of Trypanosoma cruzi.","volume":"8","author":"Lidani","year":"2017","journal-title":"Front Microbiol"},{"issue":"3","key":"2026020210305562600_bib31","doi-asserted-by":"crossref","first-page":"e9721","DOI":"10.1371\/journal.pone.0009721","article-title":"Inefficient complement system clearance of Trypanosoma cruzi metacyclic trypomastigotes enables resistant strains to invade eukaryotic cells","volume":"5","author":"Cestari","year":"2010","journal-title":"PLoS One"},{"issue":"10","key":"2026020210305562600_bib32","doi-asserted-by":"crossref","first-page":"e1005902","DOI":"10.1371\/journal.ppat.1005902","article-title":"Th17 cells are more protective than Th1 cells against the intracellular parasite Trypanosoma cruzi","volume":"12","author":"Cai","year":"2016","journal-title":"PLoS Pathog"},{"issue":"1","key":"2026020210305562600_bib33","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1128\/IAI.68.1.197-204.2000","article-title":"Involvement of CD4(+) Th1 cells in systemic immunity protective against primary and secondary challenges with Trypanosoma cruzi","volume":"68","author":"Hoft","year":"2000","journal-title":"Infect Immun"},{"key":"2026020210305562600_bib34","article-title":"Cytokines, chemokines and their receptors","volume-title":"Madame Curie Bioscience Database","author":"Cameron","year":"2000"},{"issue":"3","key":"2026020210305562600_bib35","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0165-2478(88)90034-X","article-title":"Interleukin 2 production in patients with Chagas\u2019 disease: correlation with anti-parasite antibody responses","volume":"17","author":"Tarleton","year":"1988","journal-title":"Immunol Lett"},{"issue":"1","key":"2026020210305562600_bib36","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev-immunol-042617-053352","article-title":"Signaling and function of Interleukin-2 in T lymphocytes","volume":"36","author":"Ross","year":"2018","journal-title":"Annu Rev Immunol"},{"issue":"8","key":"2026020210305562600_bib37","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1371\/journal.ppat.0020077","article-title":"CD8+ T-cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes","volume":"2","author":"Martin","year":"2006","journal-title":"PLoS Pathog"},{"key":"2026020210305562600_bib38","doi-asserted-by":"crossref","first-page":"789373","DOI":"10.3389\/fcimb.2021.789373","article-title":"Trypanosoma cruzi induces B cells that regulate the CD4+ T cell response","volume":"11","author":"Somoza","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"2026020210305562600_bib39","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2567.2010.03347.x","article-title":"Trypanosoma cruzi infection induces a massive extrafollicular and follicular splenic B-cell response which is a high source of non-parasite-specific antibodies","volume":"132","author":"Bermejo","year":"2011","journal-title":"Immunology"},{"issue":"3","key":"2026020210305562600_bib40","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00281-015-0481-9","article-title":"CD8+ T cells in Trypanosoma cruzi infection","volume":"37","author":"Tarleton","year":"2015","journal-title":"Semin Immunopathol"},{"key":"2026020210305562600_bib41","doi-asserted-by":"crossref","first-page":"1075717","DOI":"10.3389\/fcimb.2022.1075717","article-title":"Trypanosoma cruzi-specific CD8+ T cells and other immunological hallmarks in chronic chagas cardiomyopathy: two decades of research","volume":"12","author":"Puerta","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"7","key":"2026020210305562600_bib42","doi-asserted-by":"crossref","first-page":"e1000514","DOI":"10.1371\/journal.ppat.1000514","article-title":"NFATc1 mediates toll-like receptor-independent innate immune responses during Trypanosoma cruzi infection","volume":"5","author":"Kayama","year":"2009","journal-title":"PLoS Pathog"},{"issue":"12","key":"2026020210305562600_bib43","doi-asserted-by":"crossref","first-page":"7540","DOI":"10.4049\/jimmunol.178.12.7540","article-title":"Type I IFN contributes to NK cell homeostasis, activation, and antitumor function","volume":"178","author":"Swann","year":"2007","journal-title":"J Immunol"},{"key":"2026020210305562600_bib44","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3389\/fcimb.2020.00099","article-title":"Trypanosoma cruzi-infected human macrophages shed proinflammatory extracellular vesicles that enhance host-cell invasion via toll-like receptor 2","volume":"10","author":"Cronemberger-Andrade","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"issue":"8","key":"2026020210305562600_bib45","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/j.1600-0854.2008.00760.x","article-title":"Rab5 activation by toll-like receptor 2 is required for Trypanosoma cruzi internalization and replication in macrophages","volume":"9","author":"Maganto-Garcia","year":"2008","journal-title":"Traffic"},{"key":"2026020210305562600_bib46","doi-asserted-by":"crossref","first-page":"1342431","DOI":"10.3389\/fimmu.2024.1342431","article-title":"New insights into Trypanosoma cruzi genetic diversity, and its influence on parasite biology and clinical outcomes","volume":"15","author":"Silvestrini","year":"2024","journal-title":"Front Immunol"},{"key":"2026020210305562600_bib47","doi-asserted-by":"crossref","first-page":"108243","DOI":"10.1016\/j.exppara.2022.108243","article-title":"Polymorphisms of the TLR4 gene: risk factor for chronicity and severity in oral vectorial Chagas disease","volume":"238","author":"S\u00e1nchez","year":"2022","journal-title":"Exp Parasitol"},{"issue":"3","key":"2026020210305562600_bib48","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1084\/jem.154.3.856","article-title":"Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3","volume":"154","author":"Pangburn","year":"1981","journal-title":"J Exp Med"},{"issue":"1","key":"2026020210305562600_bib49","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.molimm.2014.03.014","article-title":"Trypanosoma cruzi calreticulin inhibits the complement lectin pathway activation by direct interaction with L-Ficolin","volume":"60","author":"Sosoniuk","year":"2014","journal-title":"Mol Immunol"},{"issue":"2","key":"2026020210305562600_bib50","first-page":"299","article-title":"gp 58\/68, a parasite component that contributes to the escape of the trypomastigote form of T. cruzi from damage by the human alternative complement pathway","volume":"65","author":"Fischer","year":"1988","journal-title":"Immunology"},{"issue":"17","key":"2026020210305562600_bib51","doi-asserted-by":"crossref","first-page":"6593","DOI":"10.1073\/pnas.83.17.6593","article-title":"Evasion of alternative complement pathway by Trypanosoma cruzi results from inefficient binding of factor B","volume":"83","author":"Joiner","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026020210305562600_bib52","doi-asserted-by":"crossref","first-page":"178947","DOI":"10.1155\/2015\/178947","article-title":"Immune evasion strategies of Trypanosoma cruzi","volume":"2015","author":"Fl\u00e1via Nardy","year":"2015","journal-title":"J Immunol Res"},{"key":"2026020210305562600_bib53","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.3389\/fimmu.2020.01838","article-title":"The thymus in chagas disease: molecular interactions involved in abnormal T-cell migration and differentiation","volume":"11","author":"P\u00e9rez","year":"2020","journal-title":"Front Immunol"},{"issue":"4","key":"2026020210305562600_bib54","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/1521-4141(200204)32:4<1003::AID-IMMU1003>3.0.CO;2-P","article-title":"Cruzipain, a major Trypanosoma cruzi antigen, conditions the host immune response in favor of parasite","volume":"32","author":"Giordanengo","year":"2002","journal-title":"Eur J Immunol"},{"issue":"3","key":"2026020210305562600_bib55","doi-asserted-by":"crossref","first-page":"110728","DOI":"10.1016\/j.celrep.2022.110728","article-title":"Human IL-10-producing B cells have diverse states that are induced from multiple B cell subsets","volume":"39","author":"Glass","year":"2022","journal-title":"Cell Rep"},{"key":"2026020210305562600_bib56","doi-asserted-by":"crossref","first-page":"611795","DOI":"10.3389\/fimmu.2021.611795","article-title":"Immunosuppressive mechanisms of regulatory B cells","volume":"12","author":"Catal\u00e1n","year":"2021","journal-title":"Front Immunol"},{"issue":"5","key":"2026020210305562600_bib57","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1128\/IAI.00031-15","article-title":"Trypanosoma cruzi trans-sialidase prevents elicitation of Th1 cell response via interleukin 10 and downregulates Th1 effector cells","volume":"83","author":"Ruiz D\u00edaz","year":"2015","journal-title":"Infect Immun"},{"key":"2026020210305562600_bib58","first-page":"632436","article-title":"CD4+ CD25+ FOXP3+ Treg cells induced by rSSP4 derived from T. cruzi amastigotes increase parasitemia in an experimental Chagas disease model","volume":"2013","author":"Flores-Garc\u00eda","year":"2013","journal-title":"Bio Med Res Int"},{"key":"2026020210305562600_bib59","doi-asserted-by":"crossref","first-page":"758273","DOI":"10.3389\/fcimb.2021.758273","article-title":"The blockade of interleukin-2 during the acute phase of Trypanosoma cruzi infection reveals its dominant regulatory role","volume":"11","author":"Nihei","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"2026020210305562600_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13369-022-07266-7","article-title":"CRISPR\/Cas system toward the development of next-generation recombinant vaccines: current scenario and future prospects","volume":"48","author":"Naeem","year":"2023","journal-title":"Arab J Sci Eng"},{"issue":"1","key":"2026020210305562600_bib61","doi-asserted-by":"crossref","first-page":"e0347821","DOI":"10.1128\/mbio.03478-21","article-title":"Disruption of active trans-sialidase genes impairs egress from mammalian host cells and generates highly attenuated Trypanosoma cruzi parasites","volume":"13","author":"Burle-Caldas G de","year":"2022","journal-title":"mBio"},{"issue":"1","key":"2026020210305562600_bib62","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41541-023-00647-5","article-title":"Immunization with a Trypanosoma cruzi cyclophilin-19 deletion mutant protects against acute Chagas disease in mice","volume":"8","author":"Jha","year":"2023","journal-title":"NPJ Vaccines"},{"issue":"8","key":"2026020210305562600_bib63","doi-asserted-by":"crossref","first-page":"870","DOI":"10.3390\/vaccines12080870","article-title":"Treatments and the perspectives of developing a vaccine for Chagas Disease","volume":"12","author":"Farani","year":"2024","journal-title":"Vaccines"},{"issue":"1","key":"2026020210305562600_bib64","doi-asserted-by":"crossref","first-page":"18231","DOI":"10.1038\/s41598-021-97490-2","article-title":"The gene repertoire of the main cysteine protease of Trypanosoma cruzi, cruzipain, reveals four sub-types with distinct active sites","volume":"11","author":"Santos","year":"2021","journal-title":"Sci Rep"},{"key":"2026020210305562600_bib65","doi-asserted-by":"crossref","first-page":"565142","DOI":"10.3389\/fimmu.2020.565142","article-title":"Cruzipain and its physiological inhibitor, Chagasin, as a DNA-based therapeutic vaccine against Trypanosoma cruzi","volume":"11","author":"Cerny","year":"2020","journal-title":"Front Immunol"},{"key":"2026020210305562600_bib66","doi-asserted-by":"crossref","first-page":"814276","DOI":"10.3389\/fcimb.2021.814276","article-title":"Cruzipain sulfotopes-specific antibodies generate cardiac tissue abnormalities and favor Trypanosoma cruzi infection in the BALB\/c mice model of experimental Chagas disease","volume":"11","author":"Soprano","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"2026020210305562600_bib67","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s00436-025-08453-9","article-title":"Immunomodulatory activity of Trypanosoma cruzi recombinant antigen combination TSA-1-C4 and Tc24-C4 induce activation of macrophages and CD8+ T cells","volume":"124","author":"Dzul-Huchim","year":"2025","journal-title":"Parasitol Res"},{"issue":"4","key":"2026020210305562600_bib68","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3390\/pathogens14040342","article-title":"Immunogenicity of Trypanosoma cruzi multi-epitope recombinant protein as an antigen candidate for Chagas disease vaccine in humans","volume":"14","author":"Teh-Poot","year":"2025","journal-title":"Pathogens"},{"key":"2026020210305562600_bib69","doi-asserted-by":"crossref","first-page":"1297321","DOI":"10.3389\/fcimb.2024.1297321","article-title":"Vaccination with parasite-specific TcTASV proteins combined with recombinant baculovirus as a delivery platform protects against acute and chronic Trypanosoma cruzi infection","volume":"14","author":"Masip","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"2026020210305562600_bib70","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.3390\/ijms24032700","article-title":"A comprehensive review of mRNA vaccines","volume":"24","author":"Gote","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"13","key":"2026020210305562600_bib71","doi-asserted-by":"crossref","first-page":"15832","DOI":"10.1021\/acsami.3c18830","article-title":"Harnessing RNA technology to advance therapeutic vaccine antigens against Chagas disease","volume":"16","author":"Mancino","year":"2024","journal-title":"ACS Appl Mater Interfaces"}],"container-title":["Transactions of The Royal Society of Tropical Medicine and Hygiene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/trstmh\/article-pdf\/120\/2\/95\/64517347\/traf109.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/trstmh\/article-pdf\/120\/2\/95\/64517347\/traf109.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T15:34:48Z","timestamp":1770046488000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/trstmh\/article\/120\/2\/95\/8275557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":71,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,10,6]]},"published-print":{"date-parts":[[2026,2,2]]}},"URL":"https:\/\/doi.org\/10.1093\/trstmh\/traf109","relation":{},"ISSN":["0035-9203","1878-3503"],"issn-type":[{"value":"0035-9203","type":"print"},{"value":"1878-3503","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2025,10,6]]}}}